Humana Inc.

HUM Healthcare Healthcare Plans

Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

413.16 19.04 −4.41%
Market cap
$51.9B
P/E
38.8×
Fwd P/E
42.9×
Dividend yield
0.86%
F-score
6/9
Altman Z
4.66
Beneish M
−2.29
Dividend safety
61/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
37.30 18.47 26.03 24.34

+8 more quarters

P/S ratio
0.33 0.15 0.24 0.25
P/FCF ratio
24.18 16.11 77.52 20.14
P/Operating CF
24.26 16.64 (18.68) 32.23
P/B ratio
2.47 1.12 1.74 1.68
EV/Sales
0.26 0.09 0.18 0.18
EV/EBITDA
10.92 3.97 6.77 5.82
EV/FCF
19.30 9.96 60.04 14.38
Current Ratio
1.74 1.77 2.00 2.02
Net Debt/EBITDA
(6.22) (4.09) 12.27 (15.76)
Debt/Equity
0.74 0.75 0.70 0.68
Earnings Yield
2.68% 5.42% 3.84% 4.11%
Free Cash Flow Yield
4.13% 6.21% 1.29% 4.97%
Free Cash Flow per Share
15.27 9.42 (15.20) 6.95
Book value per Share
160.55 154.95 147.25 154.50
Free Cash Flow
1,834.00 1,133.00 (1,831.00) 836.00
EV/EBIT
14.07 5.28 8.84 7.53
Other line items

Show all line items

Columns are period end dates